These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 25760259)

  • 1. [Questions for the specialist examination. Discussion of acute, unilateral vestibular failure; discussion of indications and contraindications for allergen-specific immunotherapy].
    Laryngorhinootologie; 2015 Mar; 94(3):200. PubMed ID: 25760259
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on allergen immunotherapy for treatment of allergic diseases.
    Kwong KY; Leibel S
    Adv Pediatr; 2013; 60(1):141-65. PubMed ID: 24007843
    [No Abstract]   [Full Text] [Related]  

  • 3. [What is reliable in hyposensitization of IgE-induced diseases? Indications, contraindications, results and side effects].
    Fuchs T
    Internist (Berl); 1991 Dec; 32(12):721-8. PubMed ID: 1783514
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanisms of allergen-specific immunotherapy for allergic rhinitis].
    Li HB; Xu G
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):1058-62. PubMed ID: 22336028
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sublingual immunotherapy (SLIT) in the allergologist's practice].
    Mösges R; Köberlein J; Keppler J
    MMW Fortschr Med; 2008 Jun; 150 Suppl 2():79-84. PubMed ID: 18712127
    [No Abstract]   [Full Text] [Related]  

  • 6. [Allergy: who should be hyposensitized? Indications and practice of specific hyposensitization treatment of allergic diseases].
    Wüthrich B
    ZFA (Stuttgart); 1984 Jan; 60(2):67-75. PubMed ID: 6702271
    [No Abstract]   [Full Text] [Related]  

  • 7. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expert consensus on allergen specific immunotherapy of allergic rhinitis].
    ;
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):976-80. PubMed ID: 22336007
    [No Abstract]   [Full Text] [Related]  

  • 9. Sublingual immunotherapy and regulatory T cells.
    Ciprandi G; Fenoglio D; Cirillo I; Milanese M; Minuti P
    Allergy; 2006 Apr; 61(4):511-3. PubMed ID: 16512819
    [No Abstract]   [Full Text] [Related]  

  • 10. Local nasal immunotherapy.
    Andri L; Senna G
    Allergy; 1995 Feb; 50(2):190. PubMed ID: 7604946
    [No Abstract]   [Full Text] [Related]  

  • 11. [Allergen specific immunotherapy: new approaches].
    Tay F; Kündig TM; Senti G
    Praxis (Bern 1994); 2010 Oct; 99(21):1279-84. PubMed ID: 20960398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness and potentials of specific hyposensitizing treatment for allergic rhinitis in children].
    Toader V; Cosgarea M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1985; 30(2):81-8. PubMed ID: 3161145
    [No Abstract]   [Full Text] [Related]  

  • 14. Steroids vs immunotherapy for allergic rhinitis - out with the old, in with the new.
    Aasbjerg K; Backer V
    Expert Rev Clin Immunol; 2014 Feb; 10(2):171-3. PubMed ID: 24410534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specific immunotherapy: from the struggle to tolerance].
    Bischoff A
    MMW Fortschr Med; 2012 Mar; 154(5):22, 24. PubMed ID: 22624260
    [No Abstract]   [Full Text] [Related]  

  • 16. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
    Cochard MM; Eigenmann PA
    J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
    [No Abstract]   [Full Text] [Related]  

  • 17. [Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy].
    Scheinmann P; Pham Thi N; Karila C; de Blic J
    Arch Pediatr; 2012 Mar; 19(3):330-4. PubMed ID: 22306361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do indications to sublingual immunotherapy need to be revised?
    Incorvaia C; Mauro M
    J Allergy Clin Immunol; 2010 Jan; 125(1):277; author reply 277-8. PubMed ID: 20109757
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma.
    Brüggenjürgen B; Reinhold T; Brehler R; Laake E; Wiese G; Machate U; Willich SN
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):316-24. PubMed ID: 18814456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual immunotherapy.
    Lin SY; Leatherman B
    Otolaryngol Clin North Am; 2011 Jun; 44(3):753-64, x-xi. PubMed ID: 21621059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.